Physician profile
Noel E Gattenby
NPI 1003813924
$2,076.45
in general payments reported to CMS, 2019-2025
33 companies · $448 in 2025
The $448 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $55.46 · 2021: $66.66 · 2022: $184 · 2023: $476 · 2024: $477 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,401.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $364.44 | 2023-2025 | Azstarys |
| Lilly USA, LLC | $201.12 | 2019-2024 | Jardiance, Mounjaro, Trulicity |
| Pfizer INC. | $160.76 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.20 | 2022-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $138.68 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Novo Nordisk INC | $130.96 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.79 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $72.51 | 2019-2024 | Flumist Quadrivalent |
| Amgen INC. | $59.16 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $51.04 | 2022-2025 | Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $50.34 | 2019 | |
| Idorsia Pharmaceuticals US INC | $46.81 | 2024 | Quviviq |
| Medtronic, INC. | $44.06 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Seqirus USA INC | $43.17 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Glaxosmithkline, LLC. | $42.04 | 2019-2025 | Trelegy Ellipta |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $40.23 | 2023-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $38.69 | 2024 | Veozah |
| Dynavax Technologies Corporation | $35.25 | 2024 | Heplisav-B |
| Abbvie INC. | $35.01 | 2022-2025 | |
| Genentech USA, INC. | $29.35 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2019-2020 | |
| Antares Pharma, INC. | $26.75 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.90 | 2019 | |
| Arbor Pharmaceuticals, INC. | $25.20 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $24.46 | 2019 | |
| Boston Scientific Corporation | $21.68 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.11 | 2022 | |
| Exact Sciences Corporation | $19.19 | 2023 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $18.28 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $17.68 | 2022 | |
| Mayne Pharma Commercial LLC | $17.07 | 2023 | |
| Abbott Laboratories | $15.24 | 2023 | Freestyle Libre 3 |
| Shire North American Group INC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Gattenby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.